Abstract
The presence of transforming growth factor-beta receptor type II and Smad3 gene abnormality was examined in human prolactinomas by single-strand conformation polymorphism screening for gene abnormality and band shift in tumor tissue and peripheral blood samples obtained from 14 patients treated for prolactinoma. Direct sequencing of exon 4 of the transforming growth factor-beta receptor type II gene, which showed a band shift by single-strand conformation polymorphism, disclosed a single nucleotide polymorphism (rs2228048) (alleles A/G; average allele frequency, G:0.817, A:0.183) and not an active mutation. Seven of the 14 cases showed base substitution (G → A) of the single nucleotide polymorphism. Two of these 7 cases showed base substitution (G → A) in the blood sample in accordance with neoplastic transformation. Direct sequencing of exon 2 of the Smad3 gene, which showed band shift by single-strand conformation polymorphism, disclosed single nucleotide polymorphism (rs1065080) (alleles C/T; average allele frequency, C:0.947, T:0.053) and no active mutation. Four of the 14 cases showed base substitution (C → T) of the single nucleotide polymorphism. Blood samples were available for 2 of these 4 cases, and 1 of these 2 cases showed base substitution (C → T) in accordance with neoplastic transformation. Estimation of the drug sensitivity of pituitary adenoma based on analysis of peripheral blood cells needs special care.
Similar content being viewed by others
References
N Shida H Ikeda T Yoshimoto et al. (1998) ArticleTitleEstrogen-induced tumorigenesis in the pituitary gland of TGF-beta RII(+/−) knockout mice Biochim Biophys Acta 1407 79–83 Occurrence Handle9639680 Occurrence Handle1:CAS:528:DyaK1cXjvFOjsro%3D
H Ikeda T Yoshimoto N Shida et al. (2001) ArticleTitleMorphologic and molecular analysis of estrogen induced pituitary tumorigenesis in targeted disruption of transforming growth factor-beta receptor type II and/or p27 mice Endocrine 16 55–65 Occurrence Handle11822828 Occurrence Handle1:CAS:528:DC%2BD38XjtVelug%3D%3D Occurrence Handle10.1385/ENDO:16:1:55
SC Chandrasekharappa SC Guru P Manickam et al. (1997) ArticleTitlePositional cloning of the gene for multiple endocrine neoplasis-type 1 Science 276 404–407 Occurrence Handle9103196 Occurrence Handle1:CAS:528:DyaK2sXis1Khu7k%3D Occurrence Handle10.1126/science.276.5311.404
AAL Pannett RV Thakker (2001) ArticleTitleSomatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis J Clin Endocrinol Metab 86 4371–4374 Occurrence Handle11549677 Occurrence Handle1:CAS:528:DC%2BD3MXmvFCrsr8%3D Occurrence Handle10.1210/jc.86.9.4371
Z Zhuang SE Ezzat AO Vortmeyer et al. (1997) ArticleTitleMutations of the MEN1 tumor suppressor gene in pituitary tumors Cancer Res 57 5446–5451 Occurrence Handle9407947 Occurrence Handle1:CAS:528:DyaK2sXotVGnsb4%3D
TR Prezant J Levine S Melmed (1998) ArticleTitleMolecular characterization of the MEN1 tumor suppressor gene in sporadic pituitary tumors J Clin Endocrinol Metab 83 1388–1391 Occurrence Handle9543172 Occurrence Handle1:CAS:528:DyaK1cXitlynur4%3D Occurrence Handle10.1210/jc.83.4.1388
H Kaji L Canaff JJ Lebrun et al. (2001) ArticleTitleInactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling Proc Natl Acad Sci U S A 98 3837–3842 Occurrence Handle11274402 Occurrence Handle1:CAS:528:DC%2BD3MXis1Khsrc%3D Occurrence Handle10.1073/pnas.061358098
H Sowa H Kaji R Kitazawa et al. (2004) ArticleTitleMenin inactivation leads to loss of transforming growth factor beta inhibition of parathyroid cell proliferation and parathyroid hormone secretion Cancer Res 64 2222–2228 Occurrence Handle15026366 Occurrence Handle1:CAS:528:DC%2BD2cXitFCgu7Y%3D Occurrence Handle10.1158/0008-5472.CAN-03-3334
H Ikeda T Yoshimoto N Shida (1997) ArticleTitleMolecular analysis of p21 and p27 genes in human pituitary adenomas Br J Cancer 76 1119–1123 Occurrence Handle9365157 Occurrence Handle1:CAS:528:DyaK2sXntlOgtLc%3D
S Takenoshita K Hagiwara M Nagashima et al. (1996) ArticleTitleThe genomic structure of the gene encoding the human transforming growth factor type II receptor Genomics 36 341–344 Occurrence Handle8812462 Occurrence Handle1:CAS:528:DyaK28XlslWiu7g%3D Occurrence Handle10.1006/geno.1996.0471
SL Lu WC Zhang Y Akiyama et al. (1996) ArticleTitleGenomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers Cancer Res 56 4595–4598 Occurrence Handle8840968 Occurrence Handle1:CAS:528:DyaK28XmsV2isb4%3D
T Arai Y Akiyama S Okabe et al. (1998) ArticleTitleGenomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers Cancer Lett 122 157–163 Occurrence Handle9464505 Occurrence Handle1:CAS:528:DyaK2sXnsVOqsLc%3D Occurrence Handle10.1016/S0304-3835(97)00384-4
K Fujiwara H Ikeda T Yoshimoto (1998) ArticleTitleAbnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas Clin Neuropathol 17 19–26 Occurrence Handle9496536 Occurrence Handle1:STN:280:DyaK1c7lslKhsw%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikeda, H. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas. Brain Tumor Pathol 23, 7–12 (2006). https://doi.org/10.1007/s10014-006-0196-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10014-006-0196-7